<DOC>
	<DOCNO>NCT02564705</DOCNO>
	<brief_summary>The aim study compare outcomes cost-effectiveness anterior versus posterior surgical treatment lumbar Isthmic Spondylolisthesis . The primary objective compare treatment effectiveness term functional outcome measure Oswestry Disability Index ( ODI ) v2.1a compare safety outcome measure treatment-related adverse event . Secondary objective compare treatment term difference pain , quality life , health utility , need re-operation . Finally , cost-effectiveness analysis perform . This analysis take form cost-effectiveness difference treatment effect cost-minimization difference treatment efficacy .</brief_summary>
	<brief_title>Comparative Study Anterior vs. Posterior Surgical Treatment Lumbar Isthmic Spondylolisthesis</brief_title>
	<detailed_description />
	<mesh_term>Spondylolisthesis</mesh_term>
	<criteria>Aged 18 55 year , inclusive Grade I , II III ( less 75 % slip cephalad vertebra compare caudal vertebra ) isthmic spondylolisthesis single level L4 S1 Unresponsive minimum 3 month nonsurgical treatment No previous surgical treatment isthmic spondylolisthesis Patients medically suitable surgical management Patients consent surgical treatment Willing able comply Investigational Protocol ( IP ) Informed Consent Form ( ICF ) sign patient Any previous lumbar spine surgery Patient significant scoliosis ( Cobb angle great 25 degree ) Subject cauda equina syndrome define neural compression cause neurogenic bowel ( rectal incontinence ) bladder ( bladder retention incontinence ) dysfunction Subject pregnant childbearing potential currently adequate birth control method Active infection surgical site Recent history ( less 1 year ) chemical substance dependency significant psychosocial disturbance may impact outcome study participation , opinion Investigator Preexistent neurologic mental disorder would preclude accurate evaluation followup ( i.e . Alzheimer 's disease , Parkinson 's disease , unstable psychiatric disorder hallucination and/or delusion schizophrenia Participation another clinical trial drug device within past 30 day could influence outcome study Is prisoner Acquired immune deficiency syndrome ( AIDS ) AIDSrelated complex Active malignancy history invasive malignancy within last five year , exception superficial basal cell carcinoma squamous cell carcinoma skin definitely treat ; patient carcinoma situ uterine cervix treat definitely 1 year prior enrollment may enter study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>